Stock info Strongbridge Biopharma plc | Filter  Basic-Info

Stock: Strongbridge Biopharma plc (US broad)

Last Price 5.33 Max Price 5.33
Min Price 5.33 1 Year return 0.00
Sector Health Care Subsector Pharmaceuticals

Loading...

Contact info:Country: USA

Sector Review Strongbridge Biopharma plc

Loading...
Year Turnover Total sector Market share
2019 0 474,848 0.00 %
2020 0 469,560 0.00 %
2021 0 566,739 0.00 %
2022 0 640,095 0.00 %
2023 0 590,728 0.00 %

Advice Strongbridge Biopharma plc

No Records Found



News Strongbridge Biopharma plc

No Records Found

Annual reports Strongbridge Biopharma plc

No Records Found

Profile Strongbridge Biopharma plc

No Records Found

Results Strongbridge Biopharma plc

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Strongbridge Biopharma plc

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Strongbridge Biopharma plc

Details
2016
2017
2018
2019
2020
Price
0.0
0.0
0.0
0.0
5.33
Eps
0.0
0.0
0.0
0.0
Price/earnings-ratio
0.0
0.0
0.0
0.0
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
0.0
0.0
0.0
0.0
Market to book
0.0
0.0
0.0
0.0
Cashflow per stock
0.0
0.0
0.0
0.0
Stocks
0
0
0
0
Market Cap
0.00
0.00
0.00
0.00

Dividend Strongbridge Biopharma plc

Price info Strongbridge Biopharma plc

Date
Price
01 May 2026
5.33
28 Apr 2026
5.33
21 Apr 2026
5.33
14 Apr 2026
5.33
28 Jan 2026
5.33
Overig aandelennieuws
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021
Strongbridge Biopharma plc Announces Dates of Special Shareholder Meetings in Connection with the Proposed Acquisition by Xeris Pharmaceuticals, Inc.
Analist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
    ©2026 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo